Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	176.21	224.95	71.66	171.33	168.13	57.95
Short-Term Investments	140.74	2.5	145.37	0.48	-	-
Cash & Short-Term Investments	316.95	227.44	217.03	171.82	168.13	57.95
Cash Growth	28.38%	4.80%	26.31%	2.19%	190.12%	2360.81%
Accounts Receivable	29.16	16.62	-	-	-	-
Other Receivables	1.15	1.09	3.58	0.09	0.02	0.04
Receivables	30.3	17.71	3.58	0.09	0.02	0.04
Inventory	2.85	3.11	-	-	-	-
Prepaid Expenses	7.02	7.87	4.77	4.05	2.49	0.02
Restricted Cash	-	-	-	-	0.02	0.02
Total Current Assets	357.12	256.13	225.38	175.95	170.66	58.03
Property, Plant & Equipment	4.2	3.35	1.53	1.83	1.24	0.28
Long-Term Investments	3	0.63	0.48	0.66	-	-
Other Intangible Assets	8.57	3.87	-	-	-	-
Other Long-Term Assets	3.42	1.51	0.48	0.46	0.08	0.01
Total Assets	376.3	265.49	227.86	178.91	171.97	58.32
Accounts Payable	26.82	18.15	5.5	2.86	2.24	0.46
Accrued Expenses	15.72	13.52	9.21	7.26	2.87	0.3
Current Portion of Leases	0.63	0.4	0.72	0.61	0.28	0.06
Current Income Taxes Payable	-	-	-	0.06	-	-
Current Unearned Revenue	-	-	-	0.7	-	-
Other Current Liabilities	22.7	4.87	-	-	-	-
Total Current Liabilities	65.87	36.94	15.43	11.48	5.39	0.82
Long-Term Debt	71.71	29.82	19.43	-	-	-
Long-Term Leases	1.24	1.52	-	0.59	0.55	0.1
Other Long-Term Liabilities	-	0.23	0.1	0.11	0.06	-
Total Liabilities	138.82	68.5	34.96	12.18	5.99	0.92
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	574.23	441.64	301.73	213.4	198.82	0.03
Retained Earnings	-337.1	-244.66	-108.76	-46.67	-32.85	-6.03
Comprehensive Income & Other	0.35	-0	-0.07	-	-	-
Total Common Equity	237.48	196.99	192.9	166.73	165.98	-6.01
Shareholders' Equity	237.48	196.99	192.9	166.73	165.98	57.4
Total Liabilities & Equity	376.3	265.49	227.86	178.91	171.97	58.32
Total Debt	73.58	31.73	20.16	1.19	0.83	0.16
Net Cash (Debt)	243.37	195.71	196.87	170.62	167.3	57.79
Net Cash Growth	13.15%	-0.59%	15.38%	1.99%	189.50%	2353.84%
Net Cash Per Share	6.70	6.66	8.00	8.30	26.95	24.46
Filing Date Shares Outstanding	38.23	34.22	26.73	20.71	20.32	19.26
Total Common Shares Outstanding	38.2	34.21	26.73	20.7	20.32	2.65
Working Capital	291.25	219.2	209.95	164.47	165.27	57.21
Book Value Per Share	6.22	5.76	7.22	8.06	8.17	-2.27
Tangible Book Value	228.92	193.12	192.9	166.73	165.98	-6.01
Tangible Book Value Per Share	5.99	5.64	7.22	8.06	8.17	-2.27
Machinery	3.5	2.08	1.08	0.85	0.54	0.12
Leasehold Improvements	0.68	0.68	0.43	0.13	0.14	0.07

Source: S&P Capital IQ. Standard template. Financial Sources.